Intravenous Infusions (XGHA:IIL) Accumulated Depreciation : GHS0.00 Mil (As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Intravenous Infusions Accumulated Depreciation Historical Data

The historical data trend for Intravenous Infusions's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Accumulated Depreciation Chart

Intravenous Infusions Annual Data

Trend

Accumulated Depreciation

Intravenous Infusions Semi-Annual Data

Accumulated Depreciation

Intravenous Infusions Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Intravenous Infusions Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.